News

Efficacy and Safety of Ivabradine in Patients With Severe Chronic Systolic Heart Failure (from the SHIFT Study)

23.01.20141801

Ivabradine's safety profile in severe HF was indistinguishable from less severe. In conclusion, our analysis confirms that heart rate reduction with ivabradine can be safely used in severe HF and may improve clinical outcomes independently of disease severity.

Meta-Analysis of the Effect of Statins on Mortality in Patients With Preserved Ejection Fraction

22.01.20141904

No therapy has been shown to improve survival in heart failure with preserved ejection fraction (HFPEF).

Travel grants for young cardiologists to visit ESC Congress 2014 in Barcelona

21.01.20144199

February 14 is the deadline for abstract submission to European Society of Cardiology Congress 2014 to be held in Barcelona, Spain from August 30 to September 3, 2014.

URIs, Antibiotics Affect Warfarin

21.01.20141886

Having an acute upper respiratory tract infection -- with or without treatment with an antibiotic -- may be associated with excessive anti-coagulation in patients taking warfarin, a retrospective study showed, but the absolute risk of harm was low.

Тrends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010

20.01.20141807

To investigate temporal changes in survival after acute myocardial infarction by early invasive strategy.

G-CSF treatment for STEMI: final 3-year follow-up of the randomised placebo-controlled STEM-AMI trial

17.01.20141887

To assess whether granulocyte colony-stimulating factor treatment induces a sustained benefit on adverse remodelling in patients with large anterior ST-elevation myocardial infarction and left ventricular dysfunction after successful reperfusion.

Aerobic interval training in patients with heart failure and an implantable cardioverter defibrillator: a controlled study evaluating feasibility and effect

16.01.20141934

Aerobic interval training has been shown to be superior to moderate continuous exercise training in improving exercise capacity and endothelial function in patients with both coronary artery disease and heart failure.